See OMB Statement on Reverse. ... Form FDA 1572 (21 CFR 312.53(c)). 6. NAMES OF THE SUBINVESTIGATORS (e.g., research fellows, residents, ... searching existing data sources, gathering and maintaining.
Open form follow the instructions
Easily sign the form with your finger
Send filled & signed form or save
How to fill out the Fda Form 1572 Fillable online
Filling out the Fda Form 1572 Fillable is an essential step for investigators involved in clinical trials. This guide provides a clear and supportive walkthrough of each section of the form to ensure you complete it accurately and efficiently.
Follow the steps to successfully complete the Fda Form 1572 Fillable online.
- Click the ‘Get Form’ button to access the fillable version of the document.
- In section 1, provide the name and address of the investigator, ensuring all details are accurate and up to date.
- For section 2, attach your curriculum vitae or another statement of qualifications that demonstrate your expertise in clinical investigation.
- Complete section 3 by entering the name and address of the medical school, hospital, or research facility where the investigations will occur.
- In section 4, list the name and address of any clinical laboratory facilities that will be utilized during the study.
- Enter the name and address of the Institutional Review Board (IRB) in section 5, which is responsible for reviewing and approving the study.
- In section 6, include the names of any sub-investigators assisting you in the investigation, such as research fellows or associates.
- Provide the name and code number of the protocol in section 7, which is relevant to the studies you will conduct.
- For section 8, attach the required clinical protocol information based on the phase of the investigation, including specifics regarding the planned investigation, study duration, and the number of subjects involved.
- Review all filled sections for accuracy, then proceed to sign and date the form in section 10 and 11.
- After completing the form and compiling any attachments, forward the document to the sponsor for their incorporation into the Investigational New Drug Application (IND).
Complete your Fda Form 1572 Fillable online today to streamline your clinical trial process.
Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.
Related content
investigation until he/she provides the sponsor with a completed, signed Statement of...
It describes how to complete the Statement of Investigator form (Form FDA 1572). The Food...
Get answers to your most pressing questions about US Legal Forms API.
Which of the following reports must be filled using a form FDA 1572?
Which of the following reports must be filed using an Form FDA 1572? In completing Form FDA 1572, Statement of Investigator, the Investigator agrees to: Conduct or supervise the investigation personally.
Who completes Form FDA 1572?
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial.
Who must be added to 1572?
A new 1572 is required when an investigator is participating in a new protocol that is added to an active IND and when the Principal Investigator of an ongoing study changes, when a Sub-Investigator is added, and when there is a change of location in which the study is being conducted.
When should 1572 be submitted to FDA?
In cases when a new site is added or of replacement of an investigator at an existing site, a 1572 must be submitted to the FDA within a 30-day window of the site's/investigator's addition/replacement.
Do you have to submit 1572?
Under FDA regulations, a 1572 is only required for studies of investigational drugs and biologics conducted under an IND. It is not required for studies that are not done under an IND and is not applicable to investigational device studies.
What is the difference between FDA 1571 and 1572?
Form FDA 1571: Coversheet for all IND submissions. The 1571 must be signed by the Sponsor of the IND. Form FDA 1572: Statement of Investigator. The 1572 must be signed by the Principal Investigator of the clinical trial.
Who signs the 1572 document when applying for an IND?
The Form FDA 1572 is signed by the investigator and a copy is submitted to the IND Sponsor.
Does FDA Form 1572 expire?
Form Approved: OMB No. 0910-0014 Expiration Date: March 31, 2022 See OMB Statement on Reverse.
Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.
If you believe that this page should be taken down, please follow our DMCA take down process here.